publication date: Dec. 9, 2010

In this issue: 

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.”

The Lancet Corrects Henschke Letters.

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

Download (PDF 551KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.